Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence

S Lorente-Cebrián, AGV Costa… - Journal of physiology …, 2013 - Springer
The present review aims to illustrate current knowledge about the efficacy of omega-3 long-
chain polyunsaturated fatty acids (n− 3 LC-PUFAs) in treating/preventing several metabolic …

Polyunsaturated fatty acids and their potential therapeutic role in cardiovascular system disorders—a review

E Sokoła-Wysoczańska, T Wysoczański, J Wagner… - Nutrients, 2018 - mdpi.com
Cardiovascular diseases are described as the leading cause of morbidity and mortality in
modern societies. Therefore, the importance of cardiovascular diseases prevention is widely …

Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management

AFG Cicero, S Ertek, C Borghi - Current vascular …, 2009 - ingentaconnect.com
Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) from fish and fish oils appear to protect
against coronary heart disease: their dietary intake is in fact inversely associated with …

Role of ω3 longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors

MY Abeywardena, GS Patten - Endocrine, Metabolic & …, 2011 - ingentaconnect.com
Cardiovascular disease is the leading cause of mortality in many economically developed
nations, and its incidence is increasing at a rapid rate in emerging economies. Diet and …

[HTML][HTML] The potential cardiometabolic effects of long-chain omega-3 polyunsaturated fatty acids: recent updates and controversies

JH Bae, H Lim, S Lim - Advances in Nutrition, 2023 - Elsevier
Various health-related effects of long-chain (LC) omega-3 polyunsaturated fatty acids
(PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been …

A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals

MA Leslie, DJA Cohen, DM Liddle… - Lipids in health and …, 2015 - Springer
Circulating levels of triacylglycerol (TG) is a recognized risk factor for developing
cardiovascular disease, a leading cause of death worldwide. The Institute of Medicine and …

[HTML][HTML] An improvement of cardiovascular risk factors by omega-3 polyunsaturated fatty acids

H Yanai, Y Masui, H Katsuyama, H Adachi… - Journal of clinical …, 2018 - ncbi.nlm.nih.gov
An epidemiological survey in the Northwest Greenland reported that the Greenlanders have
a lower frequency of acute myocardial infarction and diabetes mellitus. The very low …

[HTML][HTML] ω-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps

KC Maki, F Eren, ME Cassens, MR Dicklin… - Advances in …, 2018 - Elsevier
Abstract The 2015 Dietary Guidelines for Americans recommend limiting the intake of
saturated fatty acids (SFAs) to< 10% of energy/d and replacing dietary SFAs with …

Omega‐3 polyunsaturated fatty acids: the way forward in times of mixed evidence

KH Weylandt, S Serini, YQ Chen, HM Su… - BioMed research …, 2015 - Wiley Online Library
Almost forty years ago, it was first hypothesized that an increased dietary intake of omega‐3
polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several …

[HTML][HTML] Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations

P Van Dael - Nutrition research and practice, 2021 - ncbi.nlm.nih.gov
Abstract Long-chain (LC) n-3 polyunsaturated fatty acids (n-3 PUFAs), in particular
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are nutrients involved in …